Skip to main content

Research

New
History

Explore

Search
Cases
Professionals

Resources

Blog
Pricing
Docs

Sign in Create account

Cases

CourtFilingsPetition dateMore filters

Case

Funded debt

Stage

Exit

Next hearing

Last activity

Petition date

Court

Novum Pharma, LLC Bankruptcy Case

Novum Pharma, LLC

Sale Process

Case No. 19-10209·Delaware·Petition date Mar 6, 2018

Research this case Track this case Sign in

OverviewProfessionals

Key professionals

Investment Banker

Teneo Capital LLC

Bankruptcy Counsel

Cole Schotz P.C.

Bankruptcy Counsel

Klehr Harrison Harvey Branzburg LLP

Chief Restructuring Officer

CR3 Partners, LLC

Judge: Kevin J. Carey
Petition assets: $10M–$50M
Petition liabilities: $50M–$100M
Industry: Healthcare

Novum Pharma, LLC is a specialty pharmaceutical company headquartered in Chicago, Illinois, that owns and markets a portfolio of topical dermatology products, including Alcortin, Alcortin A, Quinja, and Novacort. Acquired from Primus Pharmaceuticals in 2015, the company utilizes an enhanced patient access model to distribute its fungicidal gels through a network of compliant pharmacies and consignment hubs. Novum employs approximately 50 full-time staff, primarily sales representatives operating across 29 states.

Case background, summaries, and key terms are generated from the filings on this docket. Docket entries and documents come from the court.

Report a data error